MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$523,500K
Free Cash flow
$205,600K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Maturities of available-for-sale...
Proceeds from the exercise of st...
Others
Negative Cash Flow Breakdown
Purchases of property, plant, an...
Other assets and liabilities
Purchases of available-for-sale ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
333,000
274,900
364,300
338,700
Depreciation and amortization
24,200
22,600
22,800
21,900
Share-based compensation expense
43,400
33,900
39,000
39,100
Impairment of property, plant, and equipment
0
-
-
-
Impairments of property, plant, and equipment
-
-
0
0
Net unrealized losses on equity securities
13,400
-61,600
-
-
Deferred income taxes
25,700
25,900
97,700
-
Other
-24,800
-32,000
33,600
100
Accounts receivable
-1,700
-38,200
52,500
-81,600
Inventories
17,700
40,100
16,500
17,500
Accounts payable and accrued expenses
-4,000
-12,700
23,200
31,200
Other assets and liabilities
104,100
-27,000
98,200
-67,200
Net cash provided by operating activities
313,600
463,300
346,200
562,100
Purchases of property, plant, and equipment
108,000
100,800
172,900
210,500
Acquired lease intangible assets
-
-
0
5,500
Deposits
700
5,700
-5,100
5,700
Purchases of available-for-sale debt securities
69,100
701,700
520,300
385,900
Maturities of available-for-sale debt securities
265,300
269,000
485,500
182,500
Sales of available-for-sale debt securities
0
1,307,900
0
596,000
Purchase of investment in privately held company
0
25,000
25,000
30,000
Acquisitions, net of cash acquired
-
-
0
-
Net cash provided by (used in) investing activities
87,500
743,700
-227,600
140,900
Payments to repurchase common stock
0
1,500,000
0
1,000,000
Proceeds from line of credit
0
-
0
0
Repayment of line of credit
0
0
0
0
Excise tax paid on net share repurchase
0
-
0
0
Payments of debt issuance costs
3,400
-
0
0
Proceeds from the exercise of stock options
126,300
68,300
99,000
40,200
Proceeds from the issuance of stock under espp
0
5,600
0
4,300
Rsus withheld for taxes
500
58,300
600
500
Net cash used in financing activities
122,400
-1,484,400
98,400
-956,000
Net increase (decrease) in cash and cash equivalents
523,500
-277,400
217,000
-253,000
Cash and cash equivalents, beginning of period
1,279,700
1,557,100
1,340,100
1,697,200
Cash and cash equivalents, end of period
1,803,200
1,279,700
1,557,100
1,340,100
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
UTHR Cash Flow Sankey Diagram
Sankey diagram visualizing UTHR cash flow for the period
Net income
$333,000K
(-47.29%↓ Y/Y)
Proceeds from the
exercise of stock options
$126,300K
(263.98%↑ Y/Y)
Maturities of
available-for-sale debt securities
$265,300K
(-71.03%↓ Y/Y)
Share-based compensation
expense
$43,400K
(-37.64%↓ Y/Y)
Deferred income taxes
$25,700K
Other
-$24,800K
(-77.14%↓ Y/Y)
Depreciation and
amortization
$24,200K
(-40.83%↓ Y/Y)
Accounts receivable
-$1,700K
(-101.70%↓ Y/Y)
Net cash provided by
operating activities
$313,600K
(-51.97%↓ Y/Y)
Net cash used in
financing activities
$122,400K
(141.86%↑ Y/Y)
Net cash provided by
(used in) investing...
$87,500K
(118.83%↑ Y/Y)
Canceled cashflow
$139,200K
Canceled cashflow
$3,900K
Canceled cashflow
$177,800K
Net increase
(decrease) in cash and cash...
$523,500K
(602.88%↑ Y/Y)
Other assets and
liabilities
$104,100K
(108.62%↑ Y/Y)
Inventories
$17,700K
(-4.84%↓ Y/Y)
Net unrealized
losses on equity...
$13,400K
Accounts payable and
accrued expenses
-$4,000K
(-109.20%↓ Y/Y)
Payments of debt issuance
costs
$3,400K
(-70.43%↓ Y/Y)
Rsus withheld for
taxes
$500K
(-96.77%↓ Y/Y)
Purchases of property,
plant, and equipment
$108,000K
(-21.23%↓ Y/Y)
Purchases of
available-for-sale debt securities
$69,100K
(-97.24%↓ Y/Y)
Deposits
$700K
(-92.86%↓ Y/Y)
Buy us a coffee
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)